Skip Navigation

Rheumatoid Arthritis

Citations 361-370 of 841 total displayed.

Past content (since Feb 2000):

MATTERS ARISING
Reply to comment on ‘Drug-related pulmonary problems in patients with rheumatoid arthritis’ by Yazici and Yazici and ‘Pulmonary adverse events with Leflunomide—myth or reality?’ by Balakrishnan and Dasgupta
V. Saravanan and C. A. Kelly
Rheumatology 2007; 46: 372-a--a373. [Extract] [Full Text]  

EDITORIALS
Lymphoma and rheumatoid arthritis—again
D. P. M. Symmons
Rheumatology 2007; 46: 1-2. [Extract] [Full Text]  

REVIEWS
Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications
W. U. Kampen, M. Voth, J. Pinkert, and A. Krause
Rheumatology 2007; 46: 16-24. [Abstract] [Full Text]  

BASIC SCIENCE
Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-{kappa}B- and p38 MAPK-dependent signalling pathways
H.-R. Kim, M.-L. Cho, K.-W. Kim, J.-Y. Juhn, S.-Y. Hwang, C.-H. Yoon, S.-H. Park, S.-H. Lee, and H.-Y. Kim
Rheumatology 2007; 46: 57-64. [Abstract] [Full Text]  

BASIC SCIENCE
Citrullination in extra-articular manifestations of rheumatoid arthritis
T. Bongartz, T. Cantaert, S. R. Atkins, P. Harle, J. L. Myers, C. Turesson, J. H. Ryu, D. Baeten, and E. L. Matteson
Rheumatology 2007; 46: 70-75. [Abstract] [Full Text]  

CLINICAL
The –308 tumour necrosis factor-{alpha} gene polymorphism predicts therapeutic response to TNF{alpha}-blockers in rheumatoid arthritis and spondyloarthritis patients
M. Seitz, U. Wirthmüller, B. Möller, and P. M. Villiger
Rheumatology 2007; 46: 93-96. [Abstract] [Full Text]  

CLINICAL
Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus
H. Marotte, E. Fontanges, F. Bailly, F. Zoulim, C. Trepo, and P. Miossec
Rheumatology 2007; 46: 97-99. [Abstract] [Full Text]  

CLINICAL
Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis
S. Kaltenhäuser, M. Pierer, S. Arnold, M. Kamprad, C. Baerwald, H. Häntzschel, and U. Wagner
Rheumatology 2007; 46: 100-104. [Abstract] [Full Text] [ Supplementary Data ]  

CLINICAL
Ages of onset suggestive of genetic anticipation in rheumatoid arthritis multicase sibships can be explained by observational bias
C. Deighton, L. A. Criswell, R. F. Lum, and A. Silman
Rheumatology 2007; 46: 120-123. [Abstract] [Full Text]  

CLINICAL
Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns
M. Flendrie, M. C. W. Creemers, and P. L. C. M. van Riel
Rheumatology 2007; 46: 146-149. [Abstract] [Full Text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85

* Collected Resources Home

* Related collections:
 Rheumatology
 Benign Joint Hypermobility Syndrome
 Crystal Arthritis
 Diagnostics and Imaging Procedures
 Education
 Experimental Arthritis
 Fibromyalgia
 Health Economics
 Historical Medicine
 Immunogenetics
 Myositis and Muscle Disease
 Osteoarthritis and Cartilage
 Osteoporosis and Metabolic Bone Disease
 Pharmacology
 Pregnancy and Rheumatic Diseases
 Psychology: Measurement and Management of Pain
 Rehabilitation
 Rheumatoid Arthritis
 Sjogren's Syndrome
 Soft Tissue Rheumatism
 Spinal Pain
 Spondylarthropathies
 Systemic Lupus Erythematosus and Autoimmunity
 Systemic Sclerosis
 Vasculitis